Skip to main content

Table 2 The target mean RBE-weighted and absorbed doses of all SOBPs

From: Validation of the relative biological effectiveness of active-energy scanning carbon-ion radiotherapy on a commercial treatment planning system with a microdosimetic kinetic model

SOBP

Ray-MKM versus NIRS-MKM

DRBEa

Dabs-Rayb

Dabs-NIRSc

RBE Diff (%)

R21.1M6D5.8

5.8

2.39

2.40

0.42

R15.2M6D5.8

5.8

2.32

2.36

1.69

R26.5M6D5.8

5.8

2.47

2.47

0.00

R21.1M3D5.8

5.8

2.15

2.15

0.00

R21.1M12D5.8

5.8

2.68

2.71

1.11

R21.1M6D3.6

3.6

1.48

1.49

0.67

R21.1M6D8.0

8.0

3.31

3.33

0.60

  1. aThe target mean RBE-weighted dose [Gy(RBE)] of the Ray-MKM and NIRS-MKM
  2. bThe target mean absorbed doses from the Ray-MKM (Gy)
  3. cThe table indicates absorbed doses from the NIRS-MKM (Gy)
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us